Angelini Ventures
Finance · Italy · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Viale Amelia 70, Rome, Latium, ItalyWebsite
www.angeliniventures.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Angelini Ventures
Angelini Ventures is a venture capital firm that invests in BioTech and HealthTech companies, focusing on transforming healthcare through technology. With a global investment of 300 million, the firm aims to improve patient journeys and address unmet needs in vulnerable populations. They partner with entrepreneurs, investors, and academic institutions to foster innovation and enable rapid scaling of promising healthcare solutions. Their mission is to develop sustainable and transformational solutions to the healthcare challenges facing humanity.Explore more
Angelini Ventures Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Angelini Ventures your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Angelini Ventures has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Angelini Ventures
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Angelini Ventures launches new products
Funding: Get notified immidiatlly once Angelini Ventures has new funding data
Check out if Angelini Ventures is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Angelini Ventures had a recent Job posting/layoffs
Earning: See what the market has to say on Angelini Ventures recently announced quarterly report
Angelini Ventures, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Angelini Ventures is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Angelini Ventures is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Angelini Ventures.
Angelini Ventures Tech Stack
A closer look at the technologies used by Angelini Ventures
See more technologies
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Product Launch
Partnership
Partnership, Product Development, Analytics & Insights, Data Management, Operations
Angelini Ventures News & Media
Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million
Angelini Ventures marks its first portfolio exit as ResMed acquires Noctrix Health, validating its strategy of backing breakthrough healthcare innovation.Angelini Ventures Invests in Hypervision Surgical’s £17 Million Series A to Advance Real-time Hyperspectral Imaging and Improve Clinical Outcomes in Surgery
Angelini Ventures invests in Hypervision Surgical’s £17M Series A to advance AI-powered hyperspectral imaging and improve surgical outcomes
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Angelini Ventures
Sign Up For FreeTo access detailed company insights
Angelini Ventures is a venture capital firm that invests in BioTech and HealthTech companies, focusing on transforming healthcare through technology. With a global investment of 300 million, the firm aims to improve patient journeys and address unmet needs in vulnerable populations. They partner with entrepreneurs, investors, and academic instituti... Read More
